Kutaj: Benefits, Evidence, Dosage & Safety

TL;DR

Kutaj (Holarrhena antidysenterica) stem bark is Ayurveda's classical antidysenteric. A 1985 uncontrolled clinical series reported 70% symptom improvement in 40 patients with amoebiasis and giardiasis at 4 g/day bark extract for 15 days. Human reports link the bark to dizziness, hypotension and CNS-type effects; high-dose animal studies show liver injury: prolonged or unsupervised use is unsafe.

(57 words. Sources: Jamadagni et al. 2017, CCRAS review (reporting Singh 1985); Chaturvedi & Singh 1983; PMC5628520.)

What it is

Kutaj is the stem bark of Holarrhena antidysenterica (L.) Wall. ex A. DC., a deciduous small tree in the dogbane family (Apocynaceae) that grows up to about 13 m and is abundant across India, especially in the Himalayan foothills (CCRAS-authored review). Its seeds are a separate traditional drug known as Indrajava or Indrayava. The bark's best-studied constituents are steroidal alkaloids, conessine, conkurchine, kurchine, holarrhemine and related compounds, with the bark containing roughly 2% total alkaloids (same review).

The Ayurvedic Pharmacopoeia of India (Part I, pp. 107–109) contains a monograph on Kutaj (as cited in the CCRAS review's references, same review). Buyers should know that Wrightia tinctoria bark is a documented adulterant of Kutaj: the two differ in medicinal properties as well as physical and chemical characteristics (same review).

Traditional use

Kutaj is Ayurveda's archetypal antidysenteric: the species name itself encodes the indication. Classical formulations built around it include Kutajarishta, Kutajavleha and Kutajghan vati, and it is classically described as curing Pravahika (amoebiasis/dysentery), Atisara (diarrhea), Jwaratisara (secondary diarrhea), blood-related disorders, skin disorders and thirst (CCRAS-authored review). Folk and tribal use is wide: bark for gastric problems in Uttar Pradesh, dysentery and diarrhea across the subcontinent, and stem bark for skin diseases in Andhra Pradesh (same review). These are traditional claims, not clinical proof: the human studies are assessed separately below.

What modern research says

Amoebiasis and giardiasis

The most-cited human study is old and small. Singh (1985) reported an uncontrolled clinical series of H. antidysenterica stem bark extract in forty patients with clinical amoebiasis and giardiasis: the extract "improved 70% of clinical symptoms" (loose motions, constipation, flatulence, abdominal cramping, diminished appetite, mucus in stools) when given at 4 g/day per adult in three divided doses for 15 consecutive days (reported in the CCRAS review). Design details such as randomization, blinding and controls are not described in the review's report, and this finding has not been replicated in a modern randomized trial. It is a lead, not proof.

Ulcerative colitis

A small randomized, single-blind study compared a monoherbal formulation containing H. antidysenterica extract with mesalamine in chronic ulcerative colitis patients (PMC trial). The authors reported symptom-score reductions with the herbal formulation and no side effects during the study period. But this was a single small study, compared against mesalamine rather than placebo, with author-reported outcomes: it has not been replicated, and it is not evidence that kutaj treats ulcerative colitis.

Acute diarrhea

A small, poorly reported study in 60 patients with acute diarrhea (atisara), described by its authors as randomized, compared Kutaja ghana (a concentrated decoction preparation) at 250 mg three times daily for 3 days versus Sanjivani vati. The authors reported a statistically significant difference favoring Kutaja ghana (International Journal of Ayurveda and Pharma Research). The design details are too thin to assess quality: a weak signal at best.

What the evidence does not support (yet)

Most of kutaj's pharmacology beyond the gut is preclinical. A root-bark decoction inhibited stable-toxin production by enterotoxigenic E. coli in laboratory culture (CCRAS review), and seed extracts showed blood-sugar-lowering effects only in diabetic rats (same review). Cell-culture studies of leaf extracts against cancer cell lines are strictly laboratory findings, not treatment evidence (same review).

Dosage

There is no universally established dose: and the traditional preparations (bark powder, Kutajarishta, Kutajghan vati) are dosed by practitioner convention, not by modern trials. One human-study regimen described in the CCRAS review is the Singh (1985) clinical series': 4 g of stem bark extract per adult per day, in three divided doses, for 15 days (CCRAS review). The Kutaja ghana diarrhea study used 250 mg three times daily for 3 days (IJAPR trial). These are research regimens, not personal recommendations: and dysentery always needs proper medical diagnosis first.

Safety & contraindications

Kutaj is not a harmless bitter. In a 1983 report in the Indian Journal of Physiology and Pharmacology, patients given kutaj bark powder (4 g/day in three divided doses for 15 days) were monitored. Three developed distinct drug-induced symptoms, sensation of heat in the abdomen and head, nausea, flatulence, constipation, agitation, nervousness, insomnia, vertigo, syncope, weakness, dry mouth and a "lightness" of the body, and a fourth, given 6 g/day, developed hypotension (blood pressure 66/40 mm Hg) with syncope (letter; summarized in the CCRAS review).

Animal toxicity work supports caution at high or prolonged doses: extracts were safe in single doses up to 2,000 mg/kg in rats, but a 3-month subchronic study reported hepatotoxicity at 270 and 530 mg/kg/day, and the review's authors advise that "overdoses and prolonged use should be avoided" (CCRAS review).

Practical cautions: avoid in pregnancy and breastfeeding (no safety data); do not combine casually with blood-pressure-lowering drugs given the documented hypotension signal. And never self-treat bloody diarrhea or suspected amoebic dysentery: dehydration and misdiagnosis are the real dangers, and standard medical care for dysentery should not be delayed.

FAQs

What is kutaj used for in Ayurveda?

Kutaj (stem bark of Holarrhena antidysenterica) is Ayurveda's classical antidysenteric: it heads traditional formulations for dysentery (Pravahika), diarrhea (Atisara) and bloody diarrhea, with preparations like Kutajarishta, Kutajavleha and Kutajghan vati (CCRAS review). These are traditional indications, not proven effects.

Does kutaj work for dysentery?

There is one old, small uncontrolled clinical series (Singh, 1985): 40 patients with amoebiasis and giardiasis given 4 g/day of bark extract for 15 days showed 70% improvement in symptoms (CCRAS review). But design details such as randomization, blinding and controls are not described in the review's report, and it has never been replicated in a modern randomized trial: so this is a lead, not proof.

What is conessine?

Conessine is the principal steroidal alkaloid in kutaj bark (the bark holds about 2% total alkaloids) (CCRAS review). It is the compound most associated with the plant's gut effects in laboratory studies.

Is kutaj safe?

Not automatically. Human case reports describe CNS-type effects (agitation, insomnia, vertigo, syncope) and hypotension at higher doses, and a 3-month rat study showed liver injury at high doses (CCRAS review; IJPP letter). Avoid prolonged or high-dose use and use it only under qualified supervision.

Can kutaj replace antibiotics or ORS for dysentery?

No. Dysentery can dehydrate and kill; oral rehydration and proper diagnosis (amoebic vs bacterial) are the standards of care. Kutaj's human evidence is a single old clinical series: it should never be used to delay standard medical treatment.

What dose of kutaj was used in studies?

The 1985 clinical series used 4 g/day of stem bark extract in three divided doses for 15 days. An acute-diarrhea study used 250 mg of Kutaja ghana three times daily for 3 days (CCRAS review; IJAPR study). These are research regimens, not recommendations.

Sources

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.